With this focus on glucagon receptors, one study sought to target these receptors with a monoclonal antibody (mAb) or with γ-aminobutyric acid (GABA) alone or in combination to evaluate the effects in streptozotocin (STZ)-induced T1D mice [83]. This evidence concerns the gene GCGR and type 1 diabetes mellitus.